💊

Health, Disease, and Medicine Development

May 9, 2025

Topic 5: Health, Disease and the Development of Medicines

Contents Overview

  • Definitions of Health, Disease, and Susceptibility
  • Pathogens and Common Infections
  • Pathogen Spread and Disease Prevention
  • Biology Only: Lifecycle of a Virus, Plant Barriers, Aseptic Techniques, etc.
  • Human Barriers and The Immune Response
  • Immunisation and Antibiotics
  • Developing New Medicines
  • Higher and Biology Only: Monoclonal Antibodies
  • Factors Affecting Non-Communicable Diseases
  • Evaluating Treatments for Cardiovascular Disease

Key Definitions

  • Health: Complete physical, mental, and social well-being (WHO).
  • Disease: Communicable vs. Non-communicable.
    • Communicable: Can be transferred (e.g., flu, common cold).
    • Non-Communicable: Not transferable (e.g., cardiovascular disease, asthma).
  • Susceptibility: Presence of one disease can increase risk to others (e.g., HIV).

Pathogens (5.4)

  • Viruses: Use host cells to replicate, causing cell damage.
  • Bacteria: Multiply quickly, produce toxins.
  • Fungi: Produce spores, cause infections.
  • Protists: Parasitic, damage hosts.

Common Infections (5.5)

  • Cholera (Bacteria): Spread via water.
  • Tuberculosis (Bacteria): Airborne.
  • Malaria (Protists): Spread by mosquitoes.
  • HIV (Virus): Spread through body fluids.
  • Ebola (Virus): Spread through body fluids.

Pathogen Spread (5.6)

  • Direct contact, water, air.
  • Prevention by hygiene, reducing contact, vaccination.

Biology Only: Lifecycle of a Virus (5.7B)

  • Lytic Pathway: Replication in host, cell bursts.
  • Lysogenic Pathway: Virus incorporates into host DNA.

Sexually Transmitted Infections (5.8)

  • Spread through sexual contact.
  • Prevention by using barrier methods.

Plant Barriers (5.9B, 5.10B)

  • Physical Barriers: Cell wall, waxy cuticle, bark.
  • Chemical Barriers: Antimicrobial chemicals.

Human Barriers (5.12)

  • Physical: Mucus, Cilia, Skin
  • Chemical: Lysozymes, Hydrochloric acid.

Immune Response (5.13)

  • Phagocytosis: Engulfing pathogens.
  • Antibodies: Bind to antigens, aid in pathogen destruction.
  • Memory Lymphocytes: Provide immunity by remembering pathogens.

Immunisation (5.14, 5.15B)

  • Simulates infection to provide immunity.
  • Advantages: Eradicates diseases, herd immunity.
  • Disadvantages: Not always effective, rare adverse reactions.

Antibiotics (5.16)

  • Treat bacterial infections, not effective against viruses.

Aseptic Techniques (5.17B)

  • Culturing Microorganisms: Nutrient broth, agar plates.
  • Importance of sterilization to prevent contamination.

Developing New Medicines (5.20)

  • Initially discovered in plants/microorganisms.
  • Testing: Preclinical (cells, animals), clinical trials (volunteers).

Higher and Biology Only: Monoclonal Antibodies (5.21B, 5.22B)

  • Production: Hybridomas from mice lymphocytes.
  • Uses: Pregnancy tests, disease treatment, research.
  • Advantages/Disadvantages: Specific targeting but costly to develop.

Non-Communicable Diseases (5.23, 5.24)

  • Influenced by lifestyle and genetic factors.
  • Examples: Cardiovascular disease, cancers, obesity, malnutrition.
  • Prevention: Healthy diet and exercise.

Evaluating Cardiovascular Treatments (5.25)

  • Medication: Cholesterol and blood pressure management.
  • Surgical Options: Coronary artery bypass, stents.
  • Lifestyle Changes: Diet, exercise, stress management.